• Corpus ID: 214711385

Cu-DOTATATE PET / MRI for Detection of Activated Macrophages in Carotid Atherosclerotic Plaques Studies in Patients Undergoing Endarterectomy

@inproceedings{Pedersen2015CuDOTATATEP,
  title={Cu-DOTATATE PET / MRI for Detection of Activated Macrophages in Carotid Atherosclerotic Plaques Studies in Patients Undergoing Endarterectomy},
  author={Sune Folke Pedersen and Benjamin Vikj and r Sandholt and Sune H{\o}gild Keller and Adam Espe Hansen and Andreas Clemmensen and Henrik Sillesen and Liselotte H{\o}jgaard and Rasmus Sejersten Ripa and Andreas Kj},
  year={2015}
}
Carotid atherosclerosis is a major risk factor of stroke and transient ischemic attack. Randomized trials have shown that carotid endarterectomy significantly reduces the risk of recurrent stroke in patients with recent symptoms of transient ischemic attack or stroke and at least 50% stenosis of the relevant carotid artery. However, not all patients will benefit from the surgery because some will have stable plaques that are not prone to cause new thromboembolic lesions. In addition, many… 
atvb.ahajournals.org
57 Citations
Highly Influential Citations
3
Background Citations
17
Methods Citations
4
Results Citations
4

Figures and Tables from this paper

57 Citations

Citation Type

Citation Type

PET/MRI of atherosclerosis.
TLDR
An overview of PET and MRI acquisition techniques for imaging of atherosclerosis including motion correction is provided, followed by a summary of vessel wall imaging PET/MRI studies in patients with carotid and coronary artery disease.
Targeting vulnerable atherosclerotic plaque via PET-tracers aiming at cell-surface overexpression of somatostatin receptors
TLDR
Data indicates that 68Ga-DOTATATE, which is a positron emitting tomography tracer, targeting the recruitment of macrophages taking place in the vulnerable plaque, could potentially serve as an imaging probe for the detection of high-risk, prone to rupture plaques.
Molecular Imaging of Vulnerable Coronary Plaque with Radiolabeled Somatostatin Receptors (SSTR)
TLDR
This PET radiopharmaceutical has been tested in several pre-clinical and clinical studies, showing an important correlation with other risk factors and has shown high relevance to detect vulnerable, atherosclerotic plaques.
PET/CT Imaging of Unstable Carotid Plaque with 68Ga-Labeled Somatostatin Receptor Ligand
TLDR
Carotid plaque 68Ga-DOTATATE activity on PET in recently symptomatic carotid plaques is not significantly different from contralateral carotids/plaques, and it is unlikely that sst2 PET/CT imaging will have a role in the detection and characterization of symptomatic vehicle plaques.
Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective
TLDR
Adoption of molecular imaging of coronary plaque into clinical practice will depend on overcoming major hurdles, ultimately including evidence that the detection of unstable plaque can change patient management and improve outcomes.
Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond 18F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon
TLDR
Biological, chemical and medical expertise is described supporting a translational approach that will enable the development of new or the evaluation of existing PET tracers for the identification of vulnerable atherosclerotic plaques for better risk prediction and benefit to patients.
PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology
TLDR
Grounding in the principles of PET imaging of atherosclerosis, the radioligands in use and in development, its research and clinical applications, and future developments for the field are provided.
Imaging inflammation in atherosclerotic plaques: Just make it easy!
TLDR
PET imaging of plaque inflammation might represent a very useful tool to identify patients who could benefit the most from anti-inflammatory treatments and to exclude patients with other causes of inflammation who are the most likely to develop severe side effects under these drugs.
Recent Advances in the Development of PET/SPECT Probes for Atherosclerosis Imaging
TLDR
Recent advances in the development of PET/SPECT probes for visualizing atherosclerotic plaques and their application to therapy monitoring are reviewed, mainly focusing on experimental studies.
Carotid plaque inflammatory activity assessed by 2-[18F]FDG-PET imaging decrease after a neurological thromboembolic event
TLDR
A decrease in culprit lesion 2-[18F]FDG-uptake 3 months after an event indicates a decrease in inflammatory activity, suggesting that carotid plaque stabilization over time is suggested.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 44 REFERENCES
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography
TLDR
It is demonstrated that atherosclerotic plaque inflammation can be imaged with 18 FDG-PET, and that symptomatic, unstable plaques accumulate more 18FDG than asymptomatic lesions.
Gene expression and 18FDG uptake in atherosclerotic carotid plaques
TLDR
It is suggested that FDG uptake is a composite indicator of macrophage load, overall inflammatory activity and collagenolytic plaque destabilization and could prove to be an important predictor of cerebrovascular events in patients with carotid plaques.
When to image carotid plaque inflammation with FDG PET/CT
TLDR
Identification of carotid plaque inflammation with PET can be performed 1 h after FDG injection using SUVmax for plaque FDG uptake quantification, and absolute values changed over time.
Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET).
In Vivo Imaging of Macrophage Activity in the Coronary Arteries Using 68Ga-DOTATATE PET/CT: Correlation with Coronary Calcium Burden and Risk Factors
TLDR
In a series of oncologic patients, those with prior cardiovascular events and calcified atherosclerotic plaques showed significantly increased 68Ga-DOTATATE uptake in the LAD, suggesting a potential role of this tracer for plaque imaging in the coronary arteries.
Microvessel Density But Not Neoangiogenesis Is Associated with 18F-FDG Uptake in Human Atherosclerotic Carotid Plaques
TLDR
The absence of correlation between markers of neoangiogenesis and 18FDG uptake suggests a temporal separation between the process of neoangelicogenesis and inflammatory activity.
68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors
TLDR
A stronger association of increased 68Ga-DOTATATE uptake with known risk factors of cardiovascular disease as compared to 18F-FDG is found, suggesting a potential role for plaque imaging in large arteries.
Distribution of Inflammation Within Carotid Atherosclerotic Plaques With High-Risk Morphological Features: A Comparison Between Positron Emission Tomography Activity, Plaque Morphology, and Histopathology
TLDR
Inflammation, as assessed by both FDG uptake and histology, is increased in plaques containing HRM and increases with increasing number of HRM, supporting the concept that inflammation accumulates relative to the burden of morphological abnormalities.
Feasibility of simultaneous PET/MR of the carotid artery: first clinical experience and comparison to PET/CT.
TLDR
The study shows for the first time that simultaneous PET/MR of the carotid arteries is feasible in patients with increased risk of atherosclerosis and quantification of (18)F-FDG uptake correlated well despite difference in method of PET attenuation correction, reconstruction algorithm, and detector technology.
...
1
2
3
4
5
...